Business Context and Reporting Period
Company: Supernus Pharmaceuticals, Inc. (SUPN)
Filing Type: Form 8-K (Current Report)
Date of Report: May 5, 2021
Reporting Period: First Quarter ended March 31, 2021
Context: This filing serves to announce the issuance of a press release regarding Q1 2021 financial results and to schedule a conference call for investors. The detailed financial data is contained in the press release furnished as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The provided text is a cover document for the 8-K filing and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the press release (Exhibit 99.1) but are not present in the source text provided.
Material Changes
The filing text does not provide specific data to compare current period results against prior comparable periods. It only confirms that results for the first quarter ended March 31, 2021, have been issued.
Guidance, Outlook, and Risks
- Conference Call: Management hosted a conference call on May 5, 2021, at 4:30 p.m. Eastern Time to present business and financial results. A webcast was archived on the company website for 60 days.
- Forward-Looking Statements: The filing contains forward-looking statements regarding plans, strategies, and intentions. These are subject to risks and uncertainties, including those detailed in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2020.
- Legal Disclaimer: Information furnished under Item 2.02 and Item 9.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2021 revenue, net income, and cash flow figures.
- Access the archived webcast on the company website for management's commentary on the results.
- Consult the Form 10-K filed on March 8, 2021, for a comprehensive list of risk factors affecting forward-looking statements.
- Verify the trading symbol (SUPN) on The Nasdaq Global Market for current stock performance relative to the announcement.